title: Focal segmental glomerular sclerosis. To treat or not to treat? 1. It is worthwhile to give the adult patient with nephrotic syndrome the benefit of an adequate therapeutic trial?
authors.affiliation: Division of Nephrology and Dialysis, IRCCS Ospedale Maggiore di Milano, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Ponticelli
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*
chemical_list: D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents